Recently, IMP2 knockout mice were suggested to exhibit resistance towards malignancy [21], while p62/IMP2-2 transgenic mice were reported to be more prone to hepatocarcinogenesis showing a more aggressive HCC phenotype [9]. This evidence concerns the gene IGF2BP2 and hepatocellular carcinoma.